Literature DB >> 16914324

BAFF, APRIL and their receptors: structure, function and signaling.

Claudia Bossen1, Pascal Schneider.   

Abstract

BAFF, APRIL and their receptors play important immunological roles, especially in the B cell arm of the immune system. A number of splice isoforms have been described for both ligands and receptors in this subfamily, some of which are conserved between mouse and human, while others are species-specific. Structural and mutational analyses have revealed key determinants of receptor-ligand specificity. BAFF-R has a strong selectivity for BAFF; BCMA has a higher affinity for APRIL than for BAFF, while TACI binds both ligands equally well. The molecular signaling events downstream of BAFF-R, BCMA and TACI are still incompletely characterized. Survival appears to be mediated by upregulation of Bcl-2 family members through NF-kappaB activation, degradation of the pro-apototic Bim protein, and control of subcellular localization of PCKdelta. Very little is known about other signaling events associated with receptor engagement by BAFF and APRIL that lead for example to B cell activation or to CD40L-independent Ig switch.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16914324     DOI: 10.1016/j.smim.2006.04.006

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  150 in total

1.  Virally-induced upregulation of heparan sulfate on B cells via the action of type I IFN.

Authors:  Nadine Jarousse; Damian L Trujillo; Sarah Wilcox-Adelman; Laurent Coscoy
Journal:  J Immunol       Date:  2011-11-02       Impact factor: 5.422

2.  Functional interaction of CD154 protein with α5β1 integrin is totally independent from its binding to αIIbβ3 integrin and CD40 molecules.

Authors:  Youssef El Fakhry; Haydar Alturaihi; Daniel Yacoub; Lihui Liu; Wenyan Guo; Claire Leveillé; Daniel Jung; Lara Bou Khzam; Yahye Merhi; John A Wilkins; Hongmin Li; Walid Mourad
Journal:  J Biol Chem       Date:  2012-03-29       Impact factor: 5.157

Review 3.  Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responses.

Authors:  Egest J Pone; Hong Zan; Jingsong Zhang; Ahmed Al-Qahtani; Zhenming Xu; Paolo Casali
Journal:  Crit Rev Immunol       Date:  2010       Impact factor: 2.214

4.  Combination Therapy for Treating Advanced Drug-Resistant Acute Lymphoblastic Leukemia.

Authors:  Yorleny Vicioso; Hermann Gram; Rose Beck; Abhishek Asthana; Keman Zhang; Derek P Wong; John Letterio; Reshmi Parameswaran
Journal:  Cancer Immunol Res       Date:  2019-05-28       Impact factor: 11.151

5.  Surface APRIL Is Elevated on Myeloid Cells and Is Associated with Disease Activity in Patients with Rheumatoid Arthritis.

Authors:  Abby Jones Weldon; Ioana Moldovan; Marven G Cabling; Elvin A Hernandez; Sheri Hsu; Jennifer Gonzalez; Andrea Parra; Abigail Benitez; Nasim Daoud; Keith Colburn; Kimberly J Payne
Journal:  J Rheumatol       Date:  2015-03-01       Impact factor: 4.666

Review 6.  Targeting BAFF in autoimmunity.

Authors:  Anne Davidson
Journal:  Curr Opin Immunol       Date:  2010-10-21       Impact factor: 7.486

Review 7.  Antibody-Drug Conjugates for the Treatment of Hematological Malignancies: A Comprehensive Review.

Authors:  Cédric Rossi; Marie-Lorraine Chrétien; René-Olivier Casasnovas
Journal:  Target Oncol       Date:  2018-06       Impact factor: 4.493

8.  B cell activating factor (BAFF) and a proliferation inducing ligand (APRIL) mediate CD40-independent help by memory CD4 T cells.

Authors:  V Gorbacheva; K Ayasoufi; R Fan; W M Baldwin; A Valujskikh
Journal:  Am J Transplant       Date:  2014-12-12       Impact factor: 8.086

9.  Safety, pharmacokinetics and pharmacodynamics of atacicept in healthy volunteers.

Authors:  Alain Munafo; Anthony Priestley; Ivan Nestorov; Jennifer Visich; Mark Rogge
Journal:  Eur J Clin Pharmacol       Date:  2007-05-01       Impact factor: 2.953

10.  Naturally occurring mutation affecting the MyD88-binding site of TNFRSF13B impairs triggering of class switch recombination.

Authors:  Maria B Almejun; Montserrat Cols; Marta Zelazko; Matias Oleastro; Andrea Cerutti; Pablo Oppezzo; Charlotte Cunningham-Rundles; Silvia Danielian
Journal:  Eur J Immunol       Date:  2013-01-18       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.